What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy?: An analysis of the German Testicular Cancer Study Group (GTCSG) in 675 prospectively followed patients

Strahlentherapie und Onkologie

Volumn 185, Issue 6, 2009, Pages 349-354

  Claßen, Johannes ^a,b   Schmidberger, Heinz ^c   Souchon, Rainer ^b   Weissbach, Lothar ^d   Hartmann, Michael ^e   Hartmann, Jörg T ^f   Hehr, Thomas ^g   Bamberg, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b St Vincentius Kliniken gAG   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d EuromedClinic ^*  (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g MARIENHOSPITAL STUTTGART   (Germany)

Author keywords

Follow up; Paraaortic radiotherapy; Relapse; Seminoma; Stage I

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEMINOMA; SYMPTOMATOLOGY;

AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; GERMANY; HEALTH CARE COSTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 67149101043     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-1958-z     Document Type: Article

References (27)

1. P. Albers W. Albrecht F. Algaba 2005 Guidelines on testicular cancer Eur Urol 48 885 94
2. J. Aparicio J.R. Germà X.G. del Muro 2005 Risk-adapted management for patients with clinical stage I seminoma: the second Spanish Germ Cell Cancer Cooperative Group study J Clin Oncol 23 8717 23
3. M. Bamberg H. Schmidberger C. Meisner 1999 Radiotherapy for stage I, IIA/B testicular seminoma Int J Cancer 83 823 7
4. T. Bölling S. Könemann I. Ernst 2008 Late effects of thoracic irradiation in children Strahlenther Onkol 184 289 95
5. F. Bruns M. Raub U. Schäfer 2005 No predictive value of beta-HCG in patients with stage I seminoma - results of a long-term follow-up study after adjuvant radiotherapy Anticancer Res 25 1543 6
6. T.A. Buchholz T.L. Walden B.R. Prestidge 1998 Cost-effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma Cancer 82 1126 33
7. J. Classen M. Bamberg 1999 Gonadal toxicity and fertility after radiotherapy for testicular seminoma Onkologie 22 66 8
8. J. Classen H. Schmidberger C. Meisner 2004 Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German Testicular Cancer Study Group (GTCSG) Br J Cancer 90 2305 11
9. S.D. Fossa A. Horwich J.M. Russel 1999 Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial J Clin Oncol 17 1146 54
10. K.D. Jacobsen D.R. Olsen K. Fossa 1997 External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis Int J Radiat Oncol Biol Phys 38 95 102 (Pubitemid 27270947)
11. W.G. Jones S.D. Fossa G.M. Mead 2005 Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council trial TE18, European Organization for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328) J Clin Oncol 23 1200 8
12. I.O. Kiricuta J. Sauer W. Bohndorf 1996 Omission of the pelvic irradiation in stage I testicular seminoma: a study of postorchiectomy paraaortic radiotherapy Int J Radiat Oncol Biol Phys 35 293 8
13. S. Krege J. Beyer S. Souchon 2008 European consensus conference on diagnosis and treatment of germ cell cancer: a report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I Eur Urol 53 478 96
14. J.E. Livsey B. Taylor N. Mobarek 2001 Patterns of relapse following radiotherapy for stage I seminoma of the testis: implications for follow-up Clin Oncol 13 296 300
15. J.P. Logue M.A. Harris J.E. Livsey 2003 Short course para-aortic radiation for stage I seminoma of the testis Int J Radiat Oncol Biol Phys 57 1304 9
16. V. Ludwig F. Schwab M. Guckenberger 2008 Comparison of wedge versus segmented techniques in whole breast irradiation. Effects on dose exposure outside the treatment volume Strahlenther Onkol 184 307 12
17. M. Mazonakis F. Zacharopoulou S. Kachris 2007 Scattered dose to gonads and associated risks from radiotherapy for common pediatric malignancies A phantom study. Strahlenther Onkol 183 332 7
18. A.C. Müller U. Ganswindt M. Bamberg 2007 Risk of second malignancies after prostate irradiation? Strahlenther Onkol 183 605 9
19. P.D. Nathan G.R. Rustin 2003 The role of CT scanning in the surveillance of testicular tumours Clin Oncol (R Coll Radiol) 15 121 2
20. N.N. Sharda T.J. Kinsella M.A. Ritter 1996 Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma J Clin Oncol 14 2933 9
21. J.R. Spermon J.A. Witjes L.A.L.M. Kiemeney 2004 Efficacy of routine follow-up after first-line treatment for testicular cancer World J Urol 22 235 43
22. K. Sultanem L. Souhami V. Benk 1998 Para-aortic irradiation only appears to be adequate treatment for patients with stage I seminoma of the testis Int J Radiat Oncol Biol Phys 40 455 9
23. L.B. Travis R.E. Curtis H. Storm 1997 Risk of second malignant neoplasms among long-term survivors of testicular cancer J Natl Cancer Inst 89 1429 39
24. L.B. Travis S.D. Fossa S.J. Schonfeld 2005 Second cancers among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 1354 65
25. M.J. Trigo J.M. Tabernero L. Paz-Ares 2000 Tumor markers at the time of recurrence in patients with germ cell tumors Cancer 88 162 8
26. P. Warde L. Specht A. Horwich 2002 Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis J Clin Oncol 20 4448 52
27. L. Weissbach R. Bussar-Maatz U. Löhrs 1999 Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group Eur Urol 36 601 8